Apob and the Atherogenic Apob Dyslipoproteinemias Allan D. Sniderman Jacqueline P. De Graaf Patrick Couture Vascular disease remains the greatest cause of death in the developed countries and has reached…
Clinical Utility of Inflammatory Markers Kiran Musunuru Samia Mora High-sensitivity C-reactive protein (hsCRP) testing is inexpensive and has been shown to (a) predict cardiovascular risk in multiple patient groups; (b)…
Dyslipidemia in the Elderly: Special Insights to Inform the Management Strategy Michael H. Shannon William R. Hazzard The progressive and dramatic aging of the American population over the last century,…
Dyslipidemia and Atherosclerosis in Women Christian D. Nagy Catherine Y. Campbell Roger S. Blumenthal Cardiovascular disease (CVD) remains the number one killer of American women and coronary heart disease (CHD)…
Dyslipidemia in Children and Adolescents Peter O. Kwiterovich Jr. Sarah B. Clauss Brian W. McCrindle This chapter presents a theoretical and practical approach to the diagnosis and treatment of dyslipidemia…
Dyslipidemia in Renal Disease Jeffrey M. Saland Rulan S. Parekh Dyslipidemias have been commonly described in patients with chronic kidney disease (CKD) since the 1960s, with case reports demonstrating markedly…
Pathophysiology and Treatment of Dyslipidemia in Diabetes Sherita Hill Golden Miguel Munoz Atherosclerosis is the leading cause of death among individuals with diabetes, accounting for 80% of all mortality. Approximately…
Disorders of HDL Metabolism Scott M. Lilly Daniel J. Rader Observational and epidemiologic studies have strongly implicated a low level of high-density lipoprotein cholesterol (HDL-C) as an independent risk factor…
Disorders of LDL Metabolism Peter O. Kwiterovich Jr. Peter J. Espenshade Almost 100 years have passed since the classic experiments of Anitschkow and Chalatow (see Ref. 1 for review) who…
Disorders of Hypertriglyceridemia Michael A. Miller In 1959, Drs. Albrink and Mann reported the first association between elevated triglycerides (TG) and cardiovascular disease (CVD) (1). Subsequent case-control and longitudinal studies…
